Canada markets open in 5 hours

Khiron Life Sciences Corp. (KHRNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3512-0.0088 (-2.44%)
At close: 3:56PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.3600
Open0.3600
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3500 - 0.3600
52 Week Range0.2660 - 0.6170
Volume174,256
Avg. Volume287,960
Market Cap52.935M
Beta (5Y Monthly)2.02
PE Ratio (TTM)N/A
EPS (TTM)-0.1330
Earnings DateMay 27, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Khiron provides European management updates
    CNW Group

    Khiron provides European management updates

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the appointment of Franziska Katterbach as President, Khiron Europe to replace Tejinder Virk, who has resigned from the Company.

  • Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients
    CNW Group

    Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, today announces the launch of its first ZereniaTM clinic outside of Colombia, in Lima, Peru. Following the success of the Company's clinic strategy in Colombia, the new clinic has been established as a strategic partnership between Khiron and Clinica Montesur, a specialized medical provider in Lima with o

  • Khiron receives its largest European medical cannabis shipment to date
    CNW Group

    Khiron receives its largest European medical cannabis shipment to date

    Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core operations in Latin America and Europe, is pleased to announce the receipt of the Company's largest ever shipment of EU-GMP certified medical cannabis product for distribution and sale into the German market.